BRCA2 abrogation triggers innate immune responses potentiated by treatment with PARP inhibitors

Reisländer T., Lombardi EP., Groelly FJ., Miar A., Porru M., Di Vito S., Wright B., Lockstone H., Biroccio A., Harris A., Londoño-Vallejo A., Tarsounas M.

DOI

10.1038/s41467-019-11048-5

Type

Journal article

Journal

Nature Communications

Publisher

Springer Science and Business Media LLC

Publication Date

12/2019

Volume

10

Permalink Original publication